Middle East and Africa Swine Healthcare Market: By Product Type, By Disease Type, By Route of Administration, By Distribution Channel, and Country Forecast 2020-2031
Middle East and Africa Swine Healthcare Market size was valued at US$ 4.0 billion in 2024 and is expected to reach US$ 6.0 billion by 2031, growing at a significant CAGR of 5.1% from 2025-2031. Swine are domestic animals adopted for the production of meat. Swine healthcare is related to the diagnosis, prevention, and control of swine disease to make the swine healthy. Swine healthcare becomes an essential part of the swine industry for the production of healthy meat and improves the animal husbandry. Most common diseases occur in the swine include food-borne diseases, parasitic diseases, infectious diseases, and nutritional disorders among others. Vaccines are administered to the swine for the prevention of various diseases. Stringent regulatory guidelines for the swine vaccines and drug approvals, High cost and adverse effects associated with the drugs and Lack of awareness about the swine vaccines and therapeutics in underdeveloped countries are restraints of the market. This report presents market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition.
Increase in demand for healthy pork meat coupled with rise in production of pork meat, Rise in prevalence of various infectious and foodborne diseases and expansion of business by the market players and Grow in adoption of newer products and development in economic growth are drivers of the market.
The market report gives comprehensive outlook on Swine Healthcare pattern across the region with special emphasis on key countries such as Israel, South Africa and Rest of Middle East and Africa.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Market Size in 2024 |
US$ 4.0 billion |
|
Market Size in 2031 |
US$ 6.0 billion |
|
By Product Type |
|
|
By Disease Type |
|
|
By Route of Administration |
|
|
By Distribution Channel |
|
Download Free Sample Report
Middle east and africa swine healthcare market size was valued at US$ 4.0 billion in 2024 and is expected to reach US$ 6.0 billion by 2031, growing at a significant CAGR of 5.1%.
The report covers the countries market data : Saudi Arabia, United Arab Emirates, South Africa
The key players of the market are Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Ceva Sante Animale (France), Wilbur-Ellis Feed, LLC (U.S.), Vetoquinol S.A. (France)
| 1.Executive Summary |
| 2. Middle East and Africa Swine Healthcare Market Introduction |
| 2.1. Middle East and Africa Swine Healthcare Market - Taxonomy |
| 2.2. Middle East and Africa Swine Healthcare Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Disease Type |
| 2.2.3.Route of Administration |
| 2.2.4.Distribution Channel |
| 2.2.5.Country |
| 3. Middle East and Africa Swine Healthcare Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Middle East and Africa Swine Healthcare Market Analysis, 2020-2024 and Forecast 2025-2031 |
| 4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Middle East and Africa Swine Healthcare Market By Product Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 5.1. Drugs |
| 5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Feed Products |
| 5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Middle East and Africa Swine Healthcare Market By Disease Type, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 6.1. Viral Infections |
| 6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Bacterial Infections |
| 6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Parasitic Infection |
| 6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Fungal Infections |
| 6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Middle East and Africa Swine Healthcare Market By Route of Administration, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 7.1. Oral |
| 7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Parenteral |
| 7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 8. Middle East and Africa Swine Healthcare Market By Distribution Channel, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 8.1. Veterinary Hospitals |
| 8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Veterinary Pharmacies, |
| 8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Online Pharmacies |
| 8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Middle East and Africa Swine Healthcare Market By Country, 2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 9.1. GCC Countries |
| 9.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. South Africa |
| 9.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Rest of MEA |
| 9.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 10.GCC Countries Middle East and Africa Swine Healthcare Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 10.1. Product Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Drugs |
| 10.1.2.Feed Products |
| 10.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Viral Infections |
| 10.2.2.Bacterial Infections |
| 10.2.3.Parasitic Infection |
| 10.2.4.Fungal Infections |
| 10.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Oral |
| 10.3.2.Parenteral |
| 10.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Veterinary Hospitals |
| 10.4.2.Veterinary Pharmacies, |
| 10.4.3.Online Pharmacies |
| 11.South Africa Middle East and Africa Swine Healthcare Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Drugs |
| 11.1.2.Feed Products |
| 11.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Viral Infections |
| 11.2.2.Bacterial Infections |
| 11.2.3.Parasitic Infection |
| 11.2.4.Fungal Infections |
| 11.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Oral |
| 11.3.2.Parenteral |
| 11.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Veterinary Hospitals |
| 11.4.2.Veterinary Pharmacies, |
| 11.4.3.Online Pharmacies |
| 12.Rest of MEA Middle East and Africa Swine Healthcare Market ,2020-2024 and Forecast 2025-2031 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Drugs |
| 12.1.2.Feed Products |
| 12.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Viral Infections |
| 12.2.2.Bacterial Infections |
| 12.2.3.Parasitic Infection |
| 12.2.4.Fungal Infections |
| 12.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Oral |
| 12.3.2.Parenteral |
| 12.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Veterinary Hospitals |
| 12.4.2.Veterinary Pharmacies, |
| 12.4.3.Online Pharmacies |
| 13.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Viral Infections |
| 13.2.2.Bacterial Infections |
| 13.2.3.Parasitic Infection |
| 13.2.4.Fungal Infections |
| 13.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Oral |
| 13.3.2.Parenteral |
| 13.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Veterinary Hospitals |
| 13.4.2.Veterinary Pharmacies, |
| 13.4.3.Online Pharmacies |
| 14.2. Disease Type Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Viral Infections |
| 14.2.2.Bacterial Infections |
| 14.2.3.Parasitic Infection |
| 14.2.4.Fungal Infections |
| 14.3. Route of Administration Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Oral |
| 14.3.2.Parenteral |
| 14.4. Distribution Channel Analysis 2020-2024 and Forecast 2025-2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Veterinary Hospitals |
| 14.4.2.Veterinary Pharmacies, |
| 14.4.3.Online Pharmacies |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 15.2.2.Merck & Co. Inc. (U.S) |
| 15.2.3.Virbac S.A. (France) |
| 15.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 15.2.5.Elanco (U.S.) |
| 15.2.6.Bayer Animal Health (Germany) |
| 15.2.7.Ceva Sante Animale (France) |
| 15.2.8.Wilbur-Ellis Feed, LLC (U.S.) |
| 15.2.9.Vetoquinol S.A. (France) |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.
Download Sample
